Search Results - "Sánchez Carnerero, C I"

Emerging therapies in clinical development and new contributions for neuropathic pain by Alcántara Montero, A, Sánchez Carnerero, C I, Goicoechea García, C

“…Neuropathic pain is very challenging to manage because of the heterogeneity of aetiologies, symptoms, and underlying mechanisms. Conventional oral therapies…”
Get more information

Role of voltage-gated sodium channel blockers in the treatment of chronic pain: Potential uses in clinical practice based on available evidence by Alcántara Montero, A, Sánchez Carnerero, C I

“…Once patients have failed first line therapy, there is an apparent lack of knowledge on how to proceed with choosing subsequent therapy. To choose amongst…”
Get more information

Updated Guideline of the Canadian Pain Society for the pharmacological management of chronic neuropathic pain: Does it bring something new? by Alcántara Montero, A, Sánchez Carnerero, C I

Get more information

Eslicarbazepine acetate for neuropathic pain, headache, and cranial neuralgia: Evidence and experience by Alcántara Montero, A, Sánchez Carnerero, C I

“…Eslicarbazepine acetate (ESL), together with carbamazepine and oxcarbazepine, belongs to the dibenzazepine family. According to the latest clinical practice…”
Get full text

New evidence on the pharmacological management of neuropathic pain by Alcántara Montero, A, Sánchez Carnerero, C I

Get full text

Comment on a paper by Sanchez‐Larsen A et al. ‘Assessment of efficacy and safety of eslicarbazepine acetate for the treatment of trigeminal neuralgia’ by Alcántara Montero, A., Sánchez Carnerero, C.I.

Get full text

Voltage-gated sodium channel blockers: New perspectives in the treatment of neuropathic pain by Alcántara Montero, A, Sánchez Carnerero, C I

Get full text

Why does depression worsen progression and treatment response in the most frequent neurological disorders? Implications for clinical practice by Alcántara Montero, A, Sánchez Carnerero, C I

Get full text

Antiinflamatorios no esteroideos y riesgo de insuficiencia cardiaca: nuevas aportaciones by Alcántara Montero, A, Sánchez Carnerero, C.I

Get full text

Suplementos de calcio y riesgo de enfermedad cardiovascular: ¿fin de la controversia? by Alcántara Montero, A, Sánchez Carnerero, C.I

Get full text

Recomendaciones revisadas de la EULAR para el manejo de la fibromialgia by Alcántara Montero, A, Sánchez Carnerero, C.I

Get full text

Consideraciones provisionales sobre la infección por el virus Zika en mujeres gestantes: documento destinado a profesionales de salud by Sánchez Carnerero, C.I, Alcántara Montero, A

Get full text

La realización de densitometrías sin criterio aumenta la prescripción innecesaria de fármacos para la osteoporosis by Alcántara Montero, A, Sánchez Carnerero, C.I

Get full text

Las borracheras aumentan el riesgo de infarto e ictus durante la semana siguiente by Sánchez Carnerero, C.I, Alcántara Montero, A

Get full text

Inhibidores de la bomba de protones y riesgo de demencia by Alcántara Montero, A, Sánchez Carnerero, C.I

Get full text

Silodosina en el tratamiento médico expulsivo para los cálculos ureterales distales by Alcántara Montero, A, Sánchez Carnerero, C.I

Get full text

Tratar el dolor con analgésicos de venta libre: aspirina, paracetamol e ibuprofeno by Alcántara Montero, A, Sánchez Carnerero, C.I

Get full text

Existe evidencia científica para el empleo de la capsaicina tópica en el dolor de la osteoartritis? by Alcántara Montero, A, Sánchez Carnerero, C.I

Get full text

Antiinflamatorios no esteroideos y antidepresivos, una combinación peligrosa by Alcántara Montero, A, Sánchez Carnerero, C.I

Get full text

Guía CDC para la prescripción de opioides en dolor crónico by Alcántara Montero, A, Sánchez Carnerero, C.I, Ibor Vidal, P.J, Alonso Verdugo, A

Get full text